139 related articles for article (PubMed ID: 11815612)
1. Structural origins of the insulin-mimetic activity of bis(acetylacetonato)oxovanadium(IV).
Makinen MW; Brady MJ
J Biol Chem; 2002 Apr; 277(14):12215-20. PubMed ID: 11815612
[TBL] [Abstract][Full Text] [Related]
2. The vanadyl (VO2+) chelate bis(acetylacetonato)oxovanadium(IV) potentiates tyrosine phosphorylation of the insulin receptor.
Ou H; Yan L; Mustafi D; Makinen MW; Brady MJ
J Biol Inorg Chem; 2005 Dec; 10(8):874-86. PubMed ID: 16235045
[TBL] [Abstract][Full Text] [Related]
3. Chemistry and insulin-mimetic properties of bis(acetylacetonate)oxovanadium(IV) and derivatives.
Amin SS; Cryer K; Zhang B; Dutta SK; Eaton SS; Anderson OP; Miller SM; Reul BA; Brichard SM; Crans DC
Inorg Chem; 2000 Feb; 39(3):406-16. PubMed ID: 11229556
[TBL] [Abstract][Full Text] [Related]
4. Bis(acetylacetonato)-oxovanadium(iv), bis(maltolato)-oxovanadium(iv) and sodium metavanadate induce antilipolytic effects by regulating hormone-sensitive lipase and perilipin via activation of Akt.
Liu JC; Yu Y; Wang G; Wang K; Yang XG
Metallomics; 2013 Jun; 5(7):813-20. PubMed ID: 23576171
[TBL] [Abstract][Full Text] [Related]
5. The Structural Basis of Action of Vanadyl (VO
Makinen MW; Salehitazangi M
Coord Chem Rev; 2014 Nov; 279():1-22. PubMed ID: 25237207
[TBL] [Abstract][Full Text] [Related]
6. New vanadium-based magnetic resonance imaging probes: clinical potential for early detection of cancer.
Mustafi D; Peng B; Foxley S; Makinen MW; Karczmar GS; Zamora M; Ejnik J; Martin H
J Biol Inorg Chem; 2009 Nov; 14(8):1187-97. PubMed ID: 19572156
[TBL] [Abstract][Full Text] [Related]
7. Structure and conformation of bis(acetylacetonato)oxovanadium(IV) and bis(maltolato)oxovanadium(IV) in solution determined by electron nuclear double resonance spectroscopy.
Mustafi D; Makinen MW
Inorg Chem; 2005 Aug; 44(16):5580-90. PubMed ID: 16060607
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of insulin resistance in diabetic ob/ob mice by a new type of orally active insulin-mimetic vanadyl complex: bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) with VO(S(2)O(2)) coordination mode.
Takeshita S; Kawamura I; Yasuno T; Kimura C; Yamamoto T; Seki J; Tamura A; Sakurai H; Goto T
J Inorg Biochem; 2001 Jun; 85(2-3):179-86. PubMed ID: 11410238
[TBL] [Abstract][Full Text] [Related]
9. Action mechanism of bis(allixinato)oxovanadium(IV) as a novel potent insulin-mimetic complex: regulation of GLUT4 translocation and FoxO1 transcription factor.
Hiromura M; Nakayama A; Adachi Y; Doi M; Sakurai H
J Biol Inorg Chem; 2007 Nov; 12(8):1275-87. PubMed ID: 17805585
[TBL] [Abstract][Full Text] [Related]
10. The vanadyl chelate bis(acetylacetonato)oxovanadium(IV) increases the fractional uptake of 2-(fluorine-18)-2-deoxy-D-glucose by cultured human breast carcinoma cells.
Makinen MW; Bamba R; Ikejimba L; Wietholt C; Chen CT; Conzen SD
Dalton Trans; 2013 Sep; 42(33):11862-7. PubMed ID: 23644715
[TBL] [Abstract][Full Text] [Related]
11. New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals.
Liboiron BD; Thompson KH; Hanson GR; Lam E; Aebischer N; Orvig C
J Am Chem Soc; 2005 Apr; 127(14):5104-15. PubMed ID: 15810845
[TBL] [Abstract][Full Text] [Related]
12. Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV).
Willsky GR; Goldfine AB; Kostyniak PJ; McNeill JH; Yang LQ; Khan HR; Crans DC
J Inorg Biochem; 2001 May; 85(1):33-42. PubMed ID: 11377693
[TBL] [Abstract][Full Text] [Related]
13. Insulin-mimetic vanadyl(IV) complexes as evaluated by both glucose-uptake and inhibition of free fatty acids (FFA)-release in isolated rat adipocytes.
Adachi Y; Sakurai H
Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):428-33. PubMed ID: 15056957
[TBL] [Abstract][Full Text] [Related]
14. Photocytotoxic oxovanadium(IV) complexes of ferrocenyl-terpyridine and acetylacetonate derivatives.
Balaji B; Balakrishnan B; Perumalla S; Karande AA; Chakravarty AR
Eur J Med Chem; 2015 Mar; 92():332-41. PubMed ID: 25576740
[TBL] [Abstract][Full Text] [Related]
15. Bis(alpha-furancarboxylato)oxovanadium(IV) prevents and improves dexamethasone-induced insulin resistance in 3T3-L1 adipocytes.
Zuo YQ; Liu WP; Niu YF; Tian CF; Xie MJ; Chen XZ; Li L
J Pharm Pharmacol; 2008 Oct; 60(10):1335-40. PubMed ID: 18812026
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Effects on Bovine Serum Albumin Induced by Different Forms of Vanadium.
Zhang Q; Ma Y; Liu H; Gu J; Sun X
Biol Trace Elem Res; 2023 Jun; 201(6):3088-3098. PubMed ID: 35915278
[TBL] [Abstract][Full Text] [Related]
17. Kinetic characterization of the inhibition of protein tyrosine phosphatase-1B by Vanadyl (VO
Hon J; Hwang MS; Charnetzki MA; Rashed IJ; Brady PB; Quillin S; Makinen MW
J Biol Inorg Chem; 2017 Dec; 22(8):1267-1279. PubMed ID: 29071441
[TBL] [Abstract][Full Text] [Related]
18. Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds.
Noblía P; Vieites M; Torre MH; Costa-Filho AJ; Cerecetto H; González M; Lavaggi ML; Adachi Y; Sakurai H; Gambino D
J Inorg Biochem; 2006 Feb; 100(2):281-7. PubMed ID: 16386797
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of insulin signaling pathway in adipocytes by oxovanadium(IV) complexes.
Basuki W; Hiromura M; Adachi Y; Tayama K; Hattori M; Sakurai H
Biochem Biophys Res Commun; 2006 Oct; 349(3):1163-70. PubMed ID: 16970914
[TBL] [Abstract][Full Text] [Related]
20. A new insulin-mimetic vanadyl complex, (N-pyridylmethylaspartate)oxovanadium(IV) with VO(N2O2) coordination mode, and evaluation of its effect on uptake of D-glucose by Ehrlich ascites tumour cells.
Tawa R; Uchida K; Taniyama J; Fujisawa Y; Fujimoto S; Nagaoka T; Kanamori K; Sakurai H
J Pharm Pharmacol; 1999 Feb; 51(2):119-24. PubMed ID: 10217308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]